| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |